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Obesity and hyperlipidemia are a major problem in the world. Pluchea indica (L.) Less. tea (PIT) is a beverage that has various
indications. This study focused on the effect of the PIT on inhibiting adipogenesis of 3T3-L1 cells and pancreatic lipase enzyme
activity.The viability of 3T3-L1 cells was not significantly decreased after exposure to 200 to 1000𝜇gmL−1 PIT compared to controls
(𝑝 > 0.05).The PIT at 750 to 1000𝜇g mL−1 exhibited a significantly reduced lipid accumulation compared to the control (𝑝 < 0.05).
The inhibitory effects of the PIT at 250 to 1000𝜇gmL−1 on lipase activitywere significantly increased compared to control (𝑝 < 0.05).
The FTIR results showed that the integrated areas of lipids, proteins, nucleic acids, glycogen, and carbohydrates of the PIT-treated
3T3-L1 adipocytes were significantly lower than the untreated 3T3-L1 adipocytes (𝑝 < 0.05). These findings may indicate that
the PIT is not only capable of inhibiting lipids and carbohydrate accumulation in adipocytes but also has a potential to inhibit
pancreatic lipase activity. So, the PIT may be further developed to the novel lipid-lowering herbal supplement for the management
of overweight or obesity.
1. Introduction
The global prevalence of obesity is increasing worldwide
rapidly [1]. Obesity is caused by an imbalance of energy
intake and expenditure [2]. The World Health Organization
estimates that over 1.5 billion adults are overweight based on
BodyMass Index (BMI)≥ 25 and over 400million of themare
obese based on BMI ≥ 30 [1]. The consequences of an obese
population are that they are more prone to develop major
health problems such as type 2 diabetes, ischemic heart dis-
ease, stroke, and cancer [3, 4]. It is necessary to treat obese
individuals by encouraging a reduced calorific intake, inhibit-
ing pancreatic lipase and adipocyte differentiation, and stim-
ulating energy expenditure by increasing physical activity, but
also by regulating lipid metabolism and the surgical option
such as laparoscopic adjustable gastric banding (LABG) in
morbid obesity [2, 5, 6]. Reducing fat digestion and absorp-
tion can be effective in treating obesity [2]. Pancreatic lipase is
an important enzyme that can hydrolyse dietary triacylglyc-
erol to glycerol and fatty acids in the intestine [7]. Glycerol
and fatty acids are regarded as the end products of lipid diges-
tion in the gut; the inhibition of pancreatic lipase may be
considered as a fat reducing absorption therapy [7, 8]; that
is one mechanism of obesity treatment [9].
The 3T3-L1 cell line is a preadipose cell linewhich is devel-
oped from mouse cells. The 3T3-L1 preadipocyte cells will
differentiate into adipocyte cells under an appropriate condi-
tion [10]. The inhibition of adipogenesis in 3T3-L1 adipocyte
cells by Oil Red O staining method can be implied to attenu-
ate hyperlipidemia and obesity [11].
Fourier transform infrared microspectroscopy (FTIR) is
a technique which is used to obtain an infrared spectrum
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of absorption or emission with high sensitivity of different
functional groups such as lipids, carbohydrates, proteins, and
nucleic acids in biological structure. In addition, FTIR has
also been used for analysis biomolecular changes in 3T3-L1
adipocytes [11].
Conventional antiobesity and antihyperlipidemic drugs
have limited efficacies and critical adverse effects such as
Orlistat, often associated with rebound weight gain after the
cessation of drug andmany patients cannot tolerate its gastro-
intestinal side effects [12]. Simvastatin, an antihyperlipidemic
drug, can cause severe adverse event such as rhabdomyolysis
[13]. At present, there is an increased demand for using plants
in therapy instead of using synthetic drugs because it may
have minor adverse effects and traditional medicinal plants
are often cheaper and easily consumable [14].
The plant Pluchea indica (L.) Less. (P. indica) (family:
Asteraceae) is a large evergreen shrub found abundantly in
salt marshes. The plant is also known to be used in rheuma-
toid arthritis [16].The plant has also been reported to possess
diuretic effects. So far some chemical constituents have been
isolated from different parts of the plant [17]. Two new thio-
phene derivatives and two pentacyclic triterpenes have been
isolated from the root of this plant [17, 18]. The methanolic
extract of P. indica leaves showed a reduction in blood glucose
level in normal (35.12% and 36.01% for 200 and 400 mg
kg−1, respectively) and streptozotocin-induced diabetic rats
(36.10% and 41.87% for 200 and 400 mg kg−1, respectively)
[19]. The methanol fraction of P. indica root extract has been
reported to possess significant hepatoprotective properties
[20]. In a separate study the extract displayed significant anti-
inflammatory activity against glucose oxidase induced paw
oedema in vivo, inhibited hydroxyl radical and lysis of
erythrocytes induced by hydrogen peroxide, and significantly
reduced serum enzyme levels (AST, ALT, LDH, and serum
alkaline phosphatase), serum bilirubin content in acute liver
injury, and total serumprotein, albumin, and albumin/globu-
lin ratio [21].
The purpose of this study was to investigate the inhibitory
effect of the PIT on pancreatic lipase activity and adipogen-
esis. The biochemical profile in 3T3-L1 adipocytes was also
investigated using the FTIR technique.The total phenolic and
flavonoid contents in the PIT were also measured.
2. Materials and Methods
2.1. Plant Materials. Fresh herb of Pluchea indica (L.) was
collected from Nakhon Ratchasima and Northeast region
of Thailand. The plant specimen was authenticated by Dr.
Paul J Grote. Identification was made in comparison with
the voucher specimen (BKF 194428) and deposited at Forest
Herbarium, National Park, Wildlife, and Plant Conservation
Department, Ministry of Natural Resources and Environ-
ment, Thailand. This herb was washed thoroughly. The pro-
duction process was performed by the Crystal Biotechnology
Co., Ltd., and Suranaree University of Technology. PIT dry
sample was added to boiling distilled water. The concen-
tration of PIT sample was calculated from concentration of
Pluchea indica (L.) dry weight in distilled water (𝜇g mL−1),
further heated for 10min, and thenfiltered throughWhatman
No.1 paper.
2.2. Chemicals and Reagents. 3T3-L1 mouse embryonic
fibroblasts and bovine calf serum were purchased from the
American Type Culture Collection (ATCC, USA). Dulbecco’s
Modified Eagle’s medium (DMEM) with high glucose,
Penicillin, Streptomycin, N-2-hydroxyethylpiperazine-N-2-
ethane sulfonic acid (HEPES), and 3-(4,5-Dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) was obtained
fromGibco Invitrogen (Grand Island,NY). Bovine calf serum
(BCS), fetal bovine serum (FBS), andOilRedOwere obtained
from Hyclone (Logan, Utah). Insulin solution from bovine,
3-Isobutyl-1-methylxanthine (IBMX), lipase from porcine
pancreas, 4-nitrophenyl dodecanoate (pNP), Orlistat, gallic
acid, Folin–Ciocalteau reagent, and catechin were obtained
fromSigma-Aldrich (St. Louis, USA).Dexamethasone (DEX)
was obtained from G Bioscience (St. Louis, USA). Dimethyl
sulfoxide (DMSO) was obtained from Carlo Erba Reagents
S.r.l. (Chausse´e du Vexin, Val de Reuil, USA). 4-O-caffe-
oylquinic acid (4-CQ), 5-O-caffeoylquinic acid (5-CQ), 3,4-
O-dicaffeoylquinic acid (3,4-CQ), 3,5-O-dicaffeoylquinic
acid (3,5-CQ), and 4,5-O-dicaffeoylquinic acid (4,5-CQ)were
purchased from Chengdu Biopurify Phytochemicals Ltd.,
(Sichuan, China). Other reagents used were all analytical
grade.
2.3. Cell Culture. The 3T3-L1 preadipocytes were seeded in
a 6-well plate at a density of 5×105 cells/well and cultured in
DMEMwith high glucose, added with 100 UmL−1 penicillin,
100 𝜇g mL−1 streptomycin, and 10% bovine calf serum until
confluent. The cells were maintained at 37∘C in 5% CO
2
and
95% humidity.
2.4. Differentiation Procedures. Two days after confluence
(day 0), the 3T3-L1 preadipocyte cells were induced to dif-
ferentiate into adipocytes by adding differentiation medium
containing 1.0 𝜇g mL−1 insulin, 1.0 𝜇M dexamethasone, 10%
FBS, and 0.5 mM of IBMX in DMEM for 48 h (day 2). The
differentiation medium was changed to maintain medium
on day 2. The maintenance media consisted of 1.0 𝜇g mL−1
insulin and 10% FBS in DMEM for 48 h (day 4). The
medium was replaced every 48 h until day 10. The 3T3-L1
preadipocytes were treated with various concentrations of the
PIT at final concentrations (250 - 1000 𝜇gmL−1) for 48 h dur-
ing periods of the differentiation phase (at day 0, 2, 4, 6, and
8). At day 10, the differentiation of 3T3-L1 preadipocytes was
observed.
2.5. In Vitro Cytotoxic Test (MTT Assay). The cytotoxic effect
of the PIT on cell proliferation was determined using the
MTT assay [22]. Briefly, the cells were seeded in a 96-well
plate at a density of 5×103 cells/well. The cells were allowed
to adhere for 48 h and then were induced to differentiate
into adipocytes by adding differentiationmedium and treated
with PIT between 250 and 1000 𝜇g mL−1. The differentiation
mediumwas changed tomaintain medium and treated with a
PIT in various concentration on day 2, and the maintenance
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medium with a PIT in various concentrations was replaced
every 48 h until day 10. At day 10, the cytotoxic effect of
the PIT on cell proliferation was investigated. The culture
medium was removed and 0.5 mg mL−1 MTT reagent was
added, and the cells were incubated for 4 h at 37∘C.The viable
cells formed formazan crystal and were dissolved in DMSO.
The absorbance was measured at 540 nm with a microplate
spectrophotometer (Benchmark Plus, Bio-Rad, Japan).
2.6. Oil Red O and Hematoxylin Staining. Oil Red O staining
can assess the increased amount of lipid accumulation nor-
mally associated with adipocyte differentiation [23]. Briefly,
3T3-L1 preadipocytes were induced to start adipogenesis by
standard adipogenic medium and treated with a PIT at vari-
ous concentrations (250, 500, 750, and 1000 𝜇g mL−1). After
48h, differentiation medium was changed to maintaining
medium with different concentrations of the PIT. The medi-
umwith various concentrations of the PITwas replaced every
48 h with maintaining medium until day 10. The cells were
washed with PBS twice and fixed with 10% formaldehyde in
PBS for 1h. After that, cells were washed with distilled water
twice and stained with 0.5%Oil Red O solution in 60:40 (v/v)
isopropanol: distilled water for 30 min at room temperature.
The Oil Red O stained cells were washed twice with distilled
water and treated with hematoxylin solution for 10 min at
room temperature. The triglyceride droplets were washed
twice with 60% isopropanol, eluted with 100% isopropanol,
and transferred to new 96 well plates. The lipid accumulation
was quantified by measuring the absorbance at 490 nm with
a microplate spectrophotometer.
2.7. FPA-FTIR Microspectroscopy. FT-IR microspectroscopy
technique was performed to investigate the effect of the PIT
on 3T3-L1 adipocyte cells following the method of Eumkeb et
al. and Dunkhuntod et al. [11, 24] with minor modifications.
In brief, 3T3-L1 cells were seeded at the density 5×105
cells/well in a 24-well plate. The samples were divided into
4 groups, including differentiated group (DIF), PIT at 750 𝜇g
mL−1 (PIT 750), Simvastatin at 1.67 𝜇g mL−1 (SIM 1.67), and
nondifferentiate group (ND, preadipocytes). The 3T3-L1 cells
were collected after treatment for 10 days and centrifuged at
400 × g for 5 min. Cells were washed with 0.85% NaCl and
recentrifuged at 400 × g for 5 min. Cell pellets were dropped
onto Barium Fluoride (BaF
2
) optical window 13 mm Ø x 2
mm (Crystran, Crystran Ltd) and air vacuum dried for 30
min in a desiccator to eliminate the excess water.The dropped
cell slides were kept in a desiccator until analysis with FTIR.
FTIR spectra were performed by using a spectroscopy
facility, at the Synchrotron Light Research Institute (Public
Organization), Thailand. FTIR spectra were obtained on a
Bruker Vertex 27 spectrometer coupled with a Bruker Hyper-
ion 3000 microscope (Bruker Optics Inc., Ettlin-Gen, Ger-
many). The microscope was equipped with nitrogen-cooled
64x64 element MCT, FPA detector, which allowed simulta-
neous acquisition of spectral data with a 15 x objective.
The spectra were obtained in the transmission mode with
the wavenumber range of 4000-700 cm−1. Each of the images
used to construct 4x4 binning FTIR image mosaic, 4 cm−1
spectral resolution, and 64 scans.The area of the sample, from
which single spectra were acquired, was approximately 20 𝜇m
x 20 𝜇m. OPUS 7.2 software (Bruker Optics Ltd, Ettlingen,
Germany) was used to acquire FTIR spectral data and control
instrument system.
The spectra of DIF, PIT (750), SIM (1.67), and ND groups
were identified by principal component analysis (PCA) using
variability of the Unscrambler 10.1 software (CAMO Software
AS, Oslo, Norway). The spectral range of 3000-2800 cm−1
and 1800-850 cm−1 was used for WEP-treated cells. The pre-
processing of the spectra was performed by second deriva-
tive transformations using Savitzky-Golay algorithm (nine
smoothing points) and normalised with extendedmultiplica-
tive signal correction (EMSC) using the spectral regions from
3000-2800 cm−1 and 1800-950 cm−1. This method is used for
identifying the overlapping of absorption peaks, reducing
variation between replicates spectra, and correcting for base-
line shift. Score plots (2D) and loading plots were used to
represent the different classes of data and relations among
variables of the data set, respectively. The integrated peak
areas of the all groups were analysed using OPUS 7.2 software
(Bruker).
2.8. Pancreatic Lipase Assay. Lipase activity assay was based
on the lipase cleaving pNP-laureate to produce a coloured
product. The aim of this experiment was to determine if
PIT could inhibit lipase activity. Any inhibitory activity was
compared toOrlistat, a known inhibitor of lipase activity. The
method was based on the method of Guo et al. [2]. In brief,
porcine pancreas lipase type 2 was dissolved in distilled water
at a concentration of 5mgmL−1 .The solutionwas centrifuged
at 10,000 × g for 5 min, and the supernatant was collected.
Reaction substrate was prepared by pNP laurate in reaction
buffer (100 mM Tris buffer pH 8.2). 0.1% (w/v) pNP laurate
wasmixed with 5mM sodium acetate (pH 5.0) containing 1%
Triton X-100 and was heated in boiling water for 2 min until
all solid matters were dissolved. After that, the solution was
mixed well and cooled to room temperature. All test samples
were dissolved in 50% DMSO in reaction buffer. Then 20 𝜇L
of the sample and 30 𝜇L of lipase were mixed and added to
40 𝜇L reaction buffer, and the reaction was started by adding
30 𝜇L substrate solution. 50% DMSO instead of the sample
was performed as a negative control, and the solution of
Orlistat was used as a positive control. Sample blank for each
test sample was prepared by the reaction solutions without
enzyme. The mixtures were incubated at 37∘C for 6 h and
measured at 409 nm using a microplate spectrophotometer.
The inhibition rate (%) was described as
Inhibitionrate (%) = (1 − ODsample −ODsample blank
ODnegative control
)
× 100
(1)
2.9. Determination of Total Phenolic Content (TPC). The total
phenolic content was investigated using the Folin–Ciocalteu
assay as previously described by Singleton and Rupasinghe
et al. [15, 25]. In brief, 100 𝜇L of 0.2 N of Folin-Cioculteu
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was pipetted into a 96-well microtitre plate.This was followed
by the addition of either 20 𝜇L of the PIT or various con-
centrations of gallic acid prepared in methanol (0-0.0625 mg
mL−1). Finally, 80 𝜇L of 7.5% (W/V) sodium carbonate was
added and the mixture was incubated at room temperature
for 2 hours. The absorbance of the blue colour solution was
measured at 765 nm by spectrophotometry, and the total
phenolic content was determined using a gallic acid standard
curve.The resultswere expressed asmg gallic acid equivalents
(mg GAE/g) per gramme of dry weight.
2.10. Determination of Total Flavonoid Content (TFC). The
total flavonoid content was measured using an aluminium
chloride colourimetric assay [26, 27]. In brief, 125 𝜇L
deionised water was pipetted into a 96-well microtitre plate.
This was followed by either the addition of 25 𝜇L standard
catechin at various concentrations (0-0.4 mg mL−1) or the
PIT. Upon completion of the addition of standards or PIT, 10𝜇L of 5% NaNO
2
was also added.The mixture was incubated
at room temperature for 6 min. To initiate a colour change,
15 𝜇L of 10% AlCl
3
solution was added. The solution was
allowed to stand for 5 min at room temperature. To prevent a
further reaction, 50 𝜇L of 1 M NaOH was added and shaken
in microplate reader spectrophotometry for 5 min before
measuring absorbance at 595 nm.The total flavonoid content
was determined using a catechin standard curve. The results
were presented as mg catechin equivalents (mg CE/g) per
gramme of dry weight.
2.11. LC-MS/MS Instrument and Conditions. The chemical
characteristic of the PIT was investigated by using LC-
MS/MS instrument. The LC-MS/MS system was made up
of a combination of chromatographic separation Agilent
HPLC 1290 Infinity and the mass analyzer 6490 Triple Quad
LC/MS Agilent Technologies equipped with electrospray
ionization (ESI) source system, consisting of an autosampler,
a binary pump, and vacuum degasser. The chromatographic
separation was set on Agilent ZORBAX Rapid Resolution
High Definition (RRHD) SB-C18, 2.1 mm id x 150 mm (1.8𝜇m).Mobile phase systemused solventA and solvent Bwhich
consisted of 1% formic acid in water and 1% formic acid in
acetonitrile, respectively. Combination of both solvents in LC
system was set at a ratio of solvent A: solvent B, 100:0 with
gradient elution: from 30% solvent B at 10 min and 100%
solvent B at 30 min at a flow rate of 0.2 mL/min. The column
temperature was maintained at 25∘C, and the sample injec-
tion volume was set at 5 𝜇L. The stock solutions of standards
(4-CQ, 5-CQ, 3,4-CQ, 3,5-CQ, and 4,5-CQ) were prepared
to a final concentration of 1000 𝜇g mL−1 by dissolving in
methanol, and working solutions were diluted by methanol
to obtain the desired concentration and PIT sample working
solution was prepared to a final concentration of 1500 𝜇g
mL−1.
2.12. Statistical Analysis. All the data were expressed as a
mean ± standard deviation (SD). The statistical significance
difference between treatment and control groups of cell
viability, the amount of lipid accumulation, biomolecular
changes, and lipase activity was analysed by one-way analysis
of variance (ANOVA) with a Turkey’s HSD post hoc test.
Values were considered statistically significant when p < 0.05
and data were representative of at least three independent
experiments.
3. Results
3.1. In Vitro 3T3-L1 Cytotoxic Test (MTT Assay). Concentra-
tions of the PIT from 250 – 1000𝜇gmL−1 did not significantly
affect the viability of 3T3-L1 preadipocytes viability compared
to control untreated cells (Figure 1), as assessed by the MTT
assay (p > 0.05). In all subsequent experiments, doses of 1000𝜇g mL−1 or less were used.
3.2. Effect of the PIT on 3T3-L1 Preadipocyte Differentiation
and Lipid Accumulation. During differentiation of 3T3-L1
preadipocytes to adipocytes, the cells were treated with the
PIT at various concentrations (250, 500, 750, and 1000 𝜇g
mL−1), and the intracellular lipid level was quantified using
an Oil Red O staining method. The 3T3-L1 preadipocytes
exposure to differentiation medium resulted in a significant
increase of lipid accumulation in comparison to untreated
adipocytes (DIF) (p < 0.05) (Figure 3). Microscopic obser-
vation of Oil Red O and hematoxylin-stained cells exhibited
that PIT decreased Oil Red O stained droplets of mature
adipocytes in a dose-dependentmanner (Figure 2).The intra-
cellular lipid accumulation showed that PIT at 750 and 1000𝜇g mL−1 significantly decreased the intracellular lipid accu-
mulation to 76.87 ± 3.99 and 71.93 ± 2.05, respectively, com-
pared to untreated 3T3-L1 adipocytes (DIF) (p < 0.05) (Fig-
ure 3).The 33 and 50% inhibitory effects (IC
33
and IC
50
) of the
PIT on lipid accumulation were determined to be 1085.5 ±
129.40 and 1841.07 ± 272.60 𝜇g mL−1, respectively. In addi-
tion, Simvastatin at 1.67 𝜇g mL−1 exhibited a 33% lipid accu-
mulation reduction (IC
33
). The effect of Simvastatin is there-
fore 650 times more effective than a PIT. Accordingly, the
PIT concentration at 750 𝜇g mL−1 was chosen to study FTIR
microspectroscopy.
3.3. Biomolecule Changing Detected by FTIR Microspec-
troscopy. FTIRmicrospectroscopy was used to determine the
biochemical composition of preadipocytes (ND), untreated
adipocytes (DIF), Simvastatin- and PIT-treated adipocytes.
The FTIR absorption spectrum of the sample at wavelengths
between 4000 and 950 cm−1 is shown in Figure 4. The three
distinct areas of the lipid region (3000-2800 cm−1), the pro-
tein regions (1700-1500cm−1), carbohydrate, and nucleic acid
regions (1300-950 cm−1) were investigated. Hence, the spec-
trum was very difficult to analyse due to the spectral differ-
ence between the groups. In order to overcome this problem
second derivative of the spectral range at 3000-2800 cm−1 and
1800-950 cm−1 was analysed (Figures 5(a) and 5(b)).
The strong peak at 2923 cm−1 and 2854 cm−1 corresponds
to the CH
2
asymmetric and symmetric stretching frequency
(mainly lipids, with the little from proteins, carbohydrates,
and nucleic acids), respectively [28]. The decrease in signal
Evidence-Based Complementary and Alternative Medicine 5
Groups
DIFPIT(25
0)
PIT(50
0)PIT(75
0)
PIT(10
00)
SIM(1.
67) ND
C
el
l v
ia
bi
lit
y (
%
)
0
20
40
60
80
100
120
140
ab a
abc abc
bc c
bc
Figure 1: The effect of Pluchea indica (L.) tea [15] on the viability of 3T3-L1 preadipocytes. DIF = differentiate 3T3-L1 adipocytes; PIT(250)
= PIT at 250 𝜇g mL−1 treated-3T3 adipocytes; SIM(4) = Simvastatin at 1.67 𝜇g mL−1 treated-3T3 adipocytes; ND = 3T3-L1 preadipocytes
(nondifferentiated cells). Means ± SD are illustrated for three replicates. Means with the same superscript are not significantly different from
each other (Tukey’s HSD test, p < 0.05).
intensity and area of the peaks (at 2954 cm−1 and 2923 cm−1),
which reflected an absorption peak of lipids of the PIT-
treated adipocytes, presented less than untreated adipocytes
(Figure 5(a)). Then, we calculated the ratio of the integrated
area of several functional groups, including CH
2
(2938-2906
cm−1, centred at 2923 cm−1)/CH
3
(2973-2954 cm−1, centred
at 2965 cm−1) asymmetric stretching that belongs to lipids.
The results showed that the ratio of the integrated area of the
lipids region in the PIT- and Simvastatin-treated adipocytes
displayed significantly less than the untreated adipocytes
group (p < 0.05) (Figure 6(b)). The major contributor in the
spectrum ranges from 1700 to 1500 cm−1, which is attributed
to an absorption peak of proteins amide I and II. The ratio
of integrated area of several functional groups, including
CH
2
asymmetric stretching (2938-2906cm−1, centred at 2923
cm−1)/amide I (1674-1624 cm−1, centred at 1654 cm−1), that
belong to proteins of the PIT- and simvastatin-treated adipo-
cytes displayed significantly less integral area ratio than the
untreated adipocytes group (p < 0.05) (Figure 6(b)).
The signal intensity and area of the peaks of the PIT- and
simvastatin-treated adipocytes at 1157 cm−1 and 1041 cm−1
which are attributed to an absorption peak of C–O vibrations
from glycogen and other carbohydrates [29] undoubtedly
exhibited significantly less than untreated 3T3-L1 adipocytes
(p < 0.05) (Figure 6(a)).The functional group of PO
2
stretch-
ing mode from mainly nucleic acids at 1238 cm−1 and 1087
cm−1 regions of the PIT-treated adipocytes displayed signal
intensity and area less than the untreated adipocytes (Fig-
ure 5(b)) and demonstrated significantly less integrated area
than that of untreated adipocytes group (p < 0.05) (Fig-
ure 6(a)) [30].
We further investigated the second derivative spectra
using the principal component analysis (PCA). The PCA
score plot showed that PIT (750) andDIF clusterwere isolated
from SIM (1.67) and ND cluster with PC-1 (42%) and the
cluster of DIF group were separated from PIT (750), SIM
(1.67), and the ND group with PC-2 (14%) (Figure 7(a)). The
PCA loading plot was used to detect the wavelength of the
spectrum that discriminated the clustering (Figure 7(b)). PC-
1 is discriminated by negative loading in the C-H stretching
region (centred at 2919 cm−1 and 2854 cm−1), negative
loading of C-O vibrations from glycogen and other carbo-
hydrates at 1153 cm−1, positive loading of C-O vibrations
from glycogen and other carbohydrates at 1064 cm−1, protein
amide I, and amide II (positive loading centred at 1658 cm−1
and 1548 cm−1, respectively), and negative loading fromC=O
stretching vibrations of lipids ester (centred at 1734 cm−1).
These results suggest that DIF and PIT (750) groups possess
higher lipids, glycogen and other carbohydrates, and proteins
than SIM (1.67) and ND groups.
The discrimination along PC-2 expressed the separation
between DIF group and other groups which demonstrated
positive loading in C-H stretching region (centred at 2911
cm−1 and 2846 cm−1), negative loading of C-O vibrations
from glycogen and other carbohydrates at 1153 cm−1 and 1022
cm−1, positive loading of C-O vibrations from glycogen and
other carbohydrates at 1064 cm−1, protein amide I (positive
loading centred at 1627 cm−1), PO
2
-symmetric stretching
vibrations of nucleic acid (negative loading centred at 1083
cm−1), and positive loading from C=O stretching vibrations
of lipids ester (centred at 1728 cm−1).These results seem con-
sistent with PC-1 that DIF group expresses higher lipids, gly-
cogen and other carbohydrates, proteins, and nucleic acid
than other groups.
3.4. Effect of the PIT on Pancreatic Lipase Activity. Pancreatic
lipase is an enzyme responsible for the hydrolysis of lipid
into free fatty acid and glycerol. The PIT concentrations
between 250 and 1000 𝜇g mL−1 displayed significantly higher
inhibitory lipase activity than those of the controls (p < 0.05)
(Figure 8). Moreover, the IC
50
of the PIT for the inhibition
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(a) (b)
(c) (d)
(e) (f)
(g)
Figure 2: Microscopic imaging of intracellular lipid after Oil Red O and haematoxylin staining of samples. (a) = Differentiate 3T3-L1
adipocytes (untreated adipocytes); (b) = PIT at 250 𝜇g mL−1 treated adipocytes; (c) = PIT at 500 𝜇g mL−1 treated adipocytes; (d) = PIT
at 750 𝜇g mL−1 treated adipocytes; (e) = PIT at 1000 𝜇g mL−1 treated adipocytes; (f) = Simvastatin at 1.67 𝜇g mL−1 treated adipocytes; (g) =
3T3-L1 preadipocytes (nondifferentiated cells) (original magnification at x100, scale bar; 100 𝜇m and Inset view at x600, scale bar; 25 𝜇m).
of pancreatic lipase was 1708.35 ± 335.85 𝜇g mL−1, while the
inhibitory effect of the positive controlOrlistat at 6.25 to 50𝜇g
mL−1 demonstrated an IC
50
at 68.23 ± 6.67 𝜇g mL−1. Under
those circumstances, the potential strength of Orlistat on
lipase activity inhibition is approximately 25 times greater
than the PIT. These results suggest that the inhibitory impli-
cations of the PIT on pancreatic lipase activity increased in a
dose-dependent manner.
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Figure 3:The figure graphically represents the effect of the PIT on the percentage of intracellular lipid in 3T3-L1 differentiated cells after Oil
Red O staining. DIF = differentiate 3T3-L1 adipocytes (untreated adipocytes); PIT(250) = PIT at 250 𝜇g mL−1 treated adipocytes; SIM(1.67)
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replicates. Means with the same superscript are not significantly different from each other (Tukey’s HSD test, p < 0.05).
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Figure 4: Average original FTIR spectra (4000–950 cm−1) obtained from 3T3-L1 cells. DIF = differentiate 3T3-L1 adipocytes (untreated
adipocytes); PIT(750) = PIT at 750 𝜇g mL−1 treated adipocytes; SIM(1.67) = Simvastatin at 1.67 𝜇g mL−1 treated adipocytes; ND = 3T3-L1
preadipocytes (nondifferentiated cells).
3.5. Total Phenolic Content (TPC) of PIT. The total pheno-
lic content was investigated by using the Folin–Ciocalteu
colourimetric assay. Gallic acid was used as a standard of the
phenolic compound. A standard calibration curve of gallic
acid had an R2 value of 0.9991 and standard equation y =
51.696x + 0.0624. The total phenolic content was calculated
and showed as gallic acid equivalents (GAE)/g of dry weight.
The results indicated that total phenolic of the PIT was 107.95± 4.87 mg GAE/g of dry weight.
3.6. Total Flavonoid Content (TFC) of PIT. Total flavonoid
content was investigated by using the aluminium chloride
colourimetric assay and expressed regarding catechin equiv-
alent (CE)/g of dry weight. The total flavonoid content was
calculated by standard calibration curve of catechin with an
R2 value of 0.994 and the standard equation of y = 3.3315x +
0.0825. The results showed that the total flavonoid content of
PIT was 95.33 ± 0.48 mg CE/g of dry weight.
3.7. Chemical Identification of PIT by LC-MS/MS. Negative
ion mode was selected for ESI-MS analysis in this study,
and the Multiple Reaction Monitoring (MRM) mode has
been used for identification. Two pairs of MRM transition
were selected at 𝑚/𝑧 353.1󳨀→191.0 and 515󳨀→353. MRM
chromatograms of PIT and standards (4-CQ, 5-CQ, 3,4-CQ,
3,5-CQ, and 4,5-CQ) of MRM transition at 𝑚/𝑧 353󳨀→191.0
are shown inFigure 9(a).The result showed that PIThad been
detected 4-CQ and 5-CQ in the extract. Figure 9(b) revealed
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Figure 5: Average the secondary derivative spectra of 3T3-L1 cells. DIF = differentiate 3T3-L1 adipocytes (untreated adipocytes); PIT(750)
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the chromatograms of PIT and standards of MRM transition
at m/z 515󳨀→353 which explained that 3,4-CQ, 3,5-CQ, and
4,5-CQ were the main ingredients of the PIT.
The quantification of the analytes was performed. We
focused on the highest peak of chromatogram that was 3,5-
CQ, and the result from MRM data acquisitions showed that
PIT concentration 1500 𝜇g mL−1 composed of 3,5-CQ 169.93𝜇g mL−1.
4. Discussion
Obesity and hyperlipidemia are caused by an imbalance
between energy intake and energy expenditure which can
cause some of the health problems such as type 2 diabetes,
ischemic heart disease, stroke, and cancer [2, 31]. Obesity and
hyperlipidemia can be treated with conventional medicine
example Simvastatin for dyslipidemia andOrlistat for obesity,
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but the medication has limited efficacies and has some side
effects such as rhabdomyolysis [32], nausea, and vomiting
[33].Therefore, traditionalmedicine is an essential alternative
medicine to alleviate these diseases and may have minor side
effects when compared with modern medicine. Moreover, if
traditional medicine can be used alone or combined with
modern medicine, it will decrease the use of modern medi-
cine or reduce the dose and side effects of modern medicine
as well [34, 35].
P. indica (L.) was reported that it had many therapeutic
indications such as decreasing blood sugar [19] and reducing
blood pressure. In addition, folk medicine can help lower
the hyperlipidemia, but this indication has not proven the
efficacy by the researcher. Nevertheless, P. indica (L.) has
the potential for prevention and treatment of metabolic syn-
drome because it may have effects on both lower blood glu-
cose and blood lipid.Moreover, no work has been done on its
efficacy and safety.
The inhibition of adipogenesis using 3T3-L1 cells can pre-
dict the efficacy of P. indica (L.) on lipid formation inhibition
[23]. In addition, the use of MTT assay that has been widely
used to evaluate cell viability can investigate the preliminary
safety and acute toxicity of the compound. The pancreatic
lipase activity investigation can suggest the efficacy of PIT on
lipid absorption inhibition from the gastrointestinal tract to
the blood results in blood lipid reduction [2].
The MTT assay can detect the cytotoxicity of the com-
pound on the cells. Viable cells can generate MTT to for-
mazan which has a purple colour. The MTT results showed
that the viability of cells treated with a PIT at 250–1000 𝜇g
mL−1 was not significantly different compared to the controls
(DIF) (p > 0.05). These findings provide evidence that PIT at≤ 1000 𝜇g mL−1 is safe for 3T3-L1 cells. Our results are in sub-
stantial agreement with those of Srisook et al. and Pramanik
et al. that P. indica (L.) alone at 25 to 400 𝜇g mL−1 showed no
cytotoxic effect in RAW 264.7 macrophage cells [36] and at
400 mg kg−1 did not cause any side effects to rat [19].
The investigation of the adipogenesis of 3T3-L1 cell can be
tested by using Oil Red O staining technique and illuminated
by a microscope. The microscopic observation results of Oil
Red O and hematoxylin-stained cells displayed that the PIT
decreased Oil Red O stained droplets of mature adipocytes
in a dose-dependent manner. Also, we can detect the quan-
tity of lipid by eluting Oil Red O dye by 100% Isopropa-
nol andmeasuring lipid accumulation bymicroplate spectro-
photometer. Interestingly, the effect of the PIT at 750 and
1000 𝜇g mL−1 did not show significantly different in lipid
accumulation compared to 1.67𝜇gmL−1 of Simvastatin, which
is a leading lipid-lowering drug.
The main active ingredients of the PIT have been inves-
tigated by using LC-MS/MS technique. The result showed
that the main chemical compositions of the PIT were caf-
feoylquinic acid derivatives which correlated with Kongkiat-
paiboon et al. [37]. Interestingly, caffeoylquinic acid has been
reported for its effect on hyperlipidemia, where the enriching
of caffeoylquinic acid derivatives in Pandanus tectorius fruit
extract moderated hyperlipidemia and improved the liver
lipid profile in hamsters fed high fat diet and these effects
may be caused by increasing the expression of PPAR𝛼 and
its downstream genes and by upregulation of LPL and AMPK
activities [38].
The total phenolic and total flavonoid content results are
in substantial agreement with those of Susetyarini et al. [39]
that tannin which is phenolic compound was found in P.
indica (L.). Furthermore, these results are consistent with
Andarwulan et al. that the active flavonoid and phenolic com-
pounds were discovered in P. indica (L.) [40]. Likewise, P.
indica (L.) appeared to possess eudesmane derivatives, ter-
pene glycosides, benzenoids, phenylpropanoids, lignan gly-
cosides, stigmasterol glucoside, quercetin, and chlorogenic
acid [36].
Furthermore, our data are consistent with those of Hsu
et al. that flavonoids and phenolic acids caused 3T3-L1 cell
cycle arrest in the G1 phase that may play a role in the
control adipogenesis of 3T3-L1 cell andmight have the further
implication of in vivo antiobesity effects [41]. Apart from
this, the previous study reported that quercetin, which is the
one of active ingredients in P. indica (L.) [37], could inhibit
adipogenesis in 3T3-L1 adipocyte cell [42]. Moreover,
quercetin was reported to have the ability to improve hyper-
triglyceridemia, alleviate hypercholesterolemia, and elevate
HDL-cholesterol in db/db mice by decreasing the expression
of peroxisomeproliferator-activated receptor-𝛼 (PPAR-𝛼) and
sterol regulatory element-binding protein-1c (SREBP-1c) and
reducing acetyl-CoA carboxylase (ACC) activity [43]. These
results provide evidence that PITmay decrease the adipogen-
esis of the cells and have the potential to develop to be a herbal
supplement that can prevent hyperlipidemia after efficacy and
toxicity in animal and human have been investigated.
FTIR microspectroscopy has previously been used to
characterise the spectral properties of biological change in
various samples [11, 44]. These results showed that the
integrated areas of lipids, proteins, nucleic acids, glycogen,
and carbohydrates of the PIT-treated adipocytes group were
significantly lower than untreated adipocytes group (DIF)
(p < 0.05) (Figures 6(a) and 6(b)). Our results are in corre-
spondence with those of Dunkhuntod et al. that baicalein
reduces lipids, proteins, glycogen, and other carbohydrates
in baicalein-treated 3T3-L1 adipocytes compared to untreated
3T3-L1adipocytes [11]. Moreover, the decreasing of integrated
area of lipids of FTIR is consistent with theOil RedO staining
results. PCAanalysis exhibited discrimination of four clusters
of the FTIR spectra of preadipocyte (ND), untreated adipo-
cyte (DIF), and Simvastatin- and PIT-treated adipocytes
(Figures 7(a) and 7(b)).
The lipase is the enzyme responsible for the digestion of
the lipid before it is absorbed into the bloodstream. The inhi-
bition of the enzyme can reduce the absorption of lipid which
can minimise the risk of obesity and hyperlipidemia disease.
The results indicated that PIT could inhibit the enzyme lipase
activity in a dose-dependent manner and had potency less
than Orlistat for 25.04 times. These results are in corres-
pondence with with those of Zhang et al. and Birari that
polyphenolic compound like flavonoid could inhibit the
enzyme lipase activity and reduce lipid absorption in the
intestine [7, 45]. Moreover, Dunkhunthod et al. reported that
baicalein could inhibit pancreatic lipase activity [11]. Also,
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the polyphenol-rich plants extract derived from grape seed
extract, fermented oats, berry, or strawberry had been re-
ported to inhibit lipases activity, and TPC enhanced the pan-
creatic lipase inhibitory effect [46, 47]. Thus, the inhibitory
effect of the PITmay depend on the amount of TPC and TFC,
which vary with the PIT concentrations.
5. Conclusions
Our results provide evidence that the PIT can decrease lipid
accumulation in 3T3-L1 adipocytes and primarily inhibit
adipogenesis. The PIT also modifies the lipid, carbohydrate,
protein, nucleic acid and glycogen concentrations within the
cells. Furthermore, the PIT could inhibit lipase activity in
vitro. This study also demonstrates that FTIR microspec-
troscopy can provide valuable information on the biochem-
istry of 3T3-L1 adipocytes.The safety of PIT on 3T3-L1 adipo-
cytes suggests that PIT may be developed to hyperlipidemia
or anti-obesity herbal. However, these in vitro results have to
be still confirmed in an animal or human test to achieve blood
and tissue therapeutic levels.
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